Substantial shrinkage of adenomas cosecreting growth hormone and prolactin with use of cabergoline therapy.
about
Medical therapy of pituitary adenomas: effects on tumor shrinkage.Challenges and pitfalls in the diagnosis of hyperprolactinemia.Medical combination therapies in Cushing's disease.Acromegaly: clinical features at diagnosis.Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients.IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma.
P2860
Substantial shrinkage of adenomas cosecreting growth hormone and prolactin with use of cabergoline therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Substantial shrinkage of adeno ...... th use of cabergoline therapy.
@en
type
label
Substantial shrinkage of adeno ...... th use of cabergoline therapy.
@en
prefLabel
Substantial shrinkage of adeno ...... th use of cabergoline therapy.
@en
P2093
P356
P1433
P1476
Substantial shrinkage of adeno ...... ith use of cabergoline therapy
@en
P2093
Carlos E Coelho
Guilherme A F S Rollin
Lucio Vilar
Luiz Augusto Casulari
Mauro A Czepielewsk
P304
P356
10.4158/EP.13.4.396
P577
2007-07-01T00:00:00Z